Poster – High Content Screening of automated wound healing and cytotoxicity assays in 2D and 3D culture

To find anti-cancer drugs, different cellular modifications can be looked at: cell death effect on proliferating cells either in 2D culture or on spheroids (3D culture), anti-mitotic, anti-migration/invasion, anti-angiogenesis effects… Different assays can be performed to follow these different effects. High content screening is a multi-parametric technology allowing searching for poly-effects drugs. 

“Nous devons garder notre avance dans le digital”, explique Vas Narasimhan de Novartis Pharmaceuticals

Vas Narasimhan, global head development at Novartis Pharmaceuticals talks about the importance of digital nowadays in pharmaceutical companies. He also emphasis the need to combine different cells therapies to efficiently cure complex diseases. Of course for us, it’s also a confirmation of HCS future developments to test the efficiency of these combinations.